BNP Paribas Financial Markets Acquires 9,465 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

BNP Paribas Financial Markets lifted its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 5.4% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 184,482 shares of the company's stock after buying an additional 9,465 shares during the quarter. BNP Paribas Financial Markets owned about 0.15% of Henry Schein worth $13,449,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in HSIC. ING Groep NV acquired a new stake in Henry Schein during the 3rd quarter worth $63,226,000. Thompson Siegel & Walmsley LLC bought a new position in shares of Henry Schein in the 2nd quarter worth $46,683,000. Bank of Montreal Can grew its stake in shares of Henry Schein by 365.6% during the third quarter. Bank of Montreal Can now owns 711,487 shares of the company's stock worth $52,095,000 after purchasing an additional 558,689 shares during the period. SG Americas Securities LLC increased its holdings in Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock valued at $33,449,000 after purchasing an additional 432,187 shares during the last quarter. Finally, Nuance Investments LLC lifted its stake in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after buying an additional 414,748 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HSIC. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. JPMorgan Chase & Co. decreased their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Monday, August 12th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Barrington Research reissued an "outperform" rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Finally, UBS Group dropped their price target on Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $79.38.

Insider Transactions at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

NASDAQ:HSIC traded down $0.55 during mid-day trading on Monday, hitting $76.50. The stock had a trading volume of 1,522,863 shares, compared to its average volume of 1,393,980. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company's 50 day simple moving average is $71.48 and its 200 day simple moving average is $69.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a market cap of $9.54 billion, a price-to-earnings ratio of 31.71, a PEG ratio of 2.21 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's quarterly revenue was up .4% on a year-over-year basis. During the same period in the previous year, the company earned $1.32 earnings per share. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.